Central serous chorioretinopathy: what we have learnt so far.

Central serous chorioretinopathy: what we have learnt so far.

Item
http://www.wikidata.org/entity/Q35680278
Clinical efficacy of anti-VEGF medications for central serous chorioretinopathy: a meta-analysis.Visual and Anatomical Outcomes of Spironolactone Therapy in Patients with Chronic Central Serous Chorioretinopathy.Subretinal fibrin absorption after 577-nm subthreshold micropulse laser therapy in a CSC case: a brief report.Functional and morphological outcome in patients with chronic central serous chorioretinopathy treated by subthreshold micropulse laser.Antiretinal antibodies in central serous chorioretinopathy: prevalence and clinical implications.Comparison of photodynamic therapy and navigated microsecond laser for chronic central serous chorioretinopathy.Visual outcomes and anatomic changes after sub-threshold micropulse yellow laser (577-nm) treatment for chronic central serous chorioretinopathy: long-term follow-up.Intravitreal Bevacizumab and Ranibizumab in the Treatment of Acute Central Serous Chorioretihopathy: A Single Center Retrospective Study.
P2860

Central serous chorioretinopathy: what we have learnt so far.

Item
http://www.wikidata.org/entity/Q35680278
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Central serous chorioretinopathy: what we have learnt so far.
@ast
Central serous chorioretinopathy: what we have learnt so far.
@en
type
label
Central serous chorioretinopathy: what we have learnt so far.
@ast
Central serous chorioretinopathy: what we have learnt so far.
@en
prefLabel
Central serous chorioretinopathy: what we have learnt so far.
@ast
Central serous chorioretinopathy: what we have learnt so far.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P577
P698
P356
P1433
P1476
Central serous chorioretinopathy: what we have learnt so far.
@en
P2093
P2860
P304
P31
P356
P433
P478
P577
P698